AmBisome® as antifungal primary prophylaxis in patients undergoing allogeneic stem cell transplantation from alternative donor: preliminary results of phase II "Prophessor" trial

被引：0
|
作者：
Ciceri, F. [1 ]
Bacigalupo, A. [2 ]
Bregni, M. [1 ]
Busca, A. [3 ]
Giardini, C. [4 ]
Scime, R. [5 ]
Visani, G. [4 ]
Balzano, R. L. [6 ]
Picaro, L. A. [6 ]
Aversa, F. [7 ]
机构：
[1] Ist Sci San Raffaele, I-20132 Milan, Italy
[2] San Martino Hosp, Genoa, Italy
[3] Le Molinette Hosp, Turin, Italy
[4] San Salvatore Hosp, Pesaro, Italy
[5] Cervello Hosp, Palermo, Italy
[6] Gilead Sci Srl, Milan, Italy
[7] Univ Perugia, I-06100 Perugia, Italy
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [41] Preliminary results of a phase II trial of clofarabine with busulfan followed by allogeneic related or unrelated donor transplantation for the treatment of haematologic malignancies
    Agura, E.
    Vance, E.
    Berryman, R.
    Pineiro, L.
    Saracino, G.
    Woelfel, R.
    Tadic-Ovcina, M.
    Fay, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S289 - S290
  • [42] STROMAL STEM CELL THERAPY FOR PROPHYLAXIS OF ACUTE GVHD: PRELIMINARY RESULTS FROM A PHASE I TRIAL
    Maziarz, R. T.
    Bachier, C.
    Goldstein, S.
    Devine, S.
    Leis, J.
    Cooke, K.
    Perry, R.
    Van't Hof, W.
    Deans, R.
    Lazarus, H. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S222 - S223
  • [43] Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
    K. Yoshikawa
    Y. Nakazawa
    Y. Katsuyama
    K. Hirabayashi
    S. Saito
    T. Shigemura
    M. Tanaka
    R. Yanagisawa
    K. Sakashita
    K. Koike
    Infection, 2014, 42 : 639 - 647
  • [44] Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
    Yoshikawa, K.
    Nakazawa, Y.
    Katsuyama, Y.
    Hirabayashi, K.
    Saito, S.
    Shigemura, T.
    Tanaka, M.
    Yanagisawa, R.
    Sakashita, K.
    Koike, K.
    INFECTION, 2014, 42 (04) : 639 - 647
  • [45] Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysis
    Wingen-Heimann, Sebastian M.
    Cornely, Oliver A.
    Vehreschild, Maria J. G. T.
    Wisplinghoff, Hilmar
    Franke, Bernd
    Schons, Max
    von Bergwelt-Baildon, Michael
    Scheid, Christof
    Vehreschild, Joerg Janne
    MYCOSES, 2021, 64 (04) : 437 - 444
  • [46] Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC)
    Lopez-Sanchez, Cristina
    Valcarcel, David
    Gomez, Valle
    Lopez-Jimenez, Javier
    Serrano, David
    Rubio, Vicente
    Solano, Carlos
    Vazquez, Lourdes
    Ruiz-Camps, Isabel
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2020, 33 (02) : 110 - 115
  • [47] Romiplostim in patients undergoing hematopoietic stem cell transplantation: results of a phase 1/2 multicenter trial
    de latour, Regis Peffault
    Chevret, Sylvie
    Ruggeri, Anna Lisa
    Suarez, Felipe
    Souchet, Laetitia
    Michonneau, David
    de Fontbrune, Flore Sicre
    Coman, Tereza
    Dhedin, Nathalie
    Rubio, Marie Therese
    Nguyen, Stephanie
    Mohty, Mohamad
    Socie, Gerard
    BLOOD, 2020, 135 (03) : 227 - 229
  • [48] High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation: A Prospective Phase II Trial
    Giannella, Maddalena
    Ercolani, Giorgio
    Cristini, Francesco
    Morelli, Mariacristina
    Bartoletti, Michele
    Bertuzzo, Valentina
    Tedeschi, Sara
    Faenza, Stefano
    Puggioli, Cristina
    Lewis, Russell E.
    Pinna, Antonio Daniele
    Viale, Pierluigi
    TRANSPLANTATION, 2015, 99 (04) : 848 - 854
  • [49] Voriconazole prophylaxis in 120 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation
    Matteazzi, F.
    Clerici, D.
    Greco, R.
    Marcatti, M.
    Fumagalli, L.
    Peccatori, J.
    Bernardi, M.
    Ciceri, F.
    Corti, C.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S221 - S222
  • [50] Dosage, Safety and Efficacy of Posaconazole As Primary Antifungal Prophylaxis in High-Risk Recipients of Allogeneic Stem Cell Transplantation
    Letailleur, Valentin
    Jullien, Maxime
    Peterlin, Pierre
    Garnier, Alice
    Gastinne, Thomas
    Gregoire, Matthieu
    Morio, Florent
    Guillaume, Thierry
    Bene, Marie C.
    Chevallier, Patrice
    Le Bourgeois, Amandine
    BLOOD, 2022, 140 : 12859 - 12860
12345